Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells

Carcinogenesis

Volumn 28, Issue 8, 2007, Pages 1780-1787

  Jung, Joo Eun ^a   Kim, Hong Sook ^a   Lee, Chang Seok ^a   Park, Dae Hun ^b   Kim, Yong Nyun ^b   Lee, Min Jae ^c   Lee, Jung Weon ^d   Park, Jong Wan ^a   Kim, Myung Suk ^a   Ye, Sang Kyu ^a   Chung, Myung Hee ^a  

^a Seoul National University   (South Korea)

^b National Cancer Center   (South Korea)

^c Kangwon National University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)ACRYLIC ACID 2 (3,4 DIHYDROXYPHENYL) ETHYL ESTER; ANGIOGENESIS INHIBITOR; CAFFEIC ACID; CAFFEIC ACID DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; STAT3 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA CELL; CELL HYPOXIA; CELL STRAIN COS7; CONTROLLED STUDY; DOWN REGULATION; DRUG STRUCTURE; DRUG TARGETING; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANGIOGENESIS INHIBITORS; ANIMALS; ANOXIA; ANTINEOPLASTIC AGENTS; CAFFEIC ACIDS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34548059697     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm130     Document Type: Article

References (34)

1. Jung,J.E. et al. (2005) STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J., 19, 1296-1298.
2. Ferrara,N. (2005) VEGF as a therapeutic target in cancer. Oncology 69 (suppl. 3), 11-16.
3. Benjamin,L.E. et al. (1999) Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest., 103, 159-165.
4. Hockel,M. et al. (2001) Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J. Natl Cancer Inst., 93, 266-276.
5. Dachs,G.U. et al. (2000) Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur. J. Cancer 36, 1649-1660.
6. Semenza,G.L. (2002) HIF-1 and minor progression, pathophysiology and therapeutics. Trends Mol. Med., 8, S62-S67.
7. Yeo,E.J. et al. (2003) YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1. J. Natl Cancer Inst., 95, 516-525.
8. Niu,G. et al. (2002) Constitutive Stat3 activity up-regulates VEGF epression and Minor angiogenesis. Oncogene, 21, 2000-2008.
9. Zhong,Z. et al. (1994) Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science, 264, 96-98.
10. Bromberg,J. et al. (1999) Stat3 as an oncogene. Cell, 98 295-303.
11. Shahidi,F. et al. (1995) Food Phenolics. Sources, Chemistry, Effects, Applications. Technomic Publishing Company, Inc., Lancester, PA.
12. Nagaoka,T. et al. (2002) Selective antiproliferative activity of caffeic acid phenethyl ester analogues on highly liver metastatic murine colon 26-L5 carcinoma cell line. Bioorg. Med. Chem., 10, 3351-3359.
13. Vieira,O. et al. (1998) Cholesteryl ester hydroperoxide formation in myoglobin-catalyzed low density lipoprotein oxidation: Concerted antioxidant activity of caffeic and p-coumaric acids with ascorbate. Biochem. Phamacol., 55, 333-340.
14. Michaluart,P. et al. (1999) Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res., 59, 2347-2352.
15. Fernandez,M.A. et al. (1998) Anti-inflammatory activity in rats and mice of phenolic acids isolated from Scrophularia frutescens. J. Pharm. Pharmacol., 50, 1183-1186.
16. Ye,S.K. et al. (2001) The IL-7 receptor controls the accessibility of the TCRγ locus by Stat5 and histone acetylation. Immunity, 15, 813-823.
17. Yu,C.L. et al. (1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science, 269, 81-83.
18. Gray,M.J. et al. (2005) HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene, 24, 3110-3120.
19. Xu,Q. et al. (2005) Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene, 24, 5552-5560.
20. Nardini,M. et al. (1998) Effect of caffeic acid on tert-butyl hydroperoxide-induced oxidative stress in U937. Free Radic. Biol. Med., 25, 1098-1105.
21. Silva,F.A.M. et al. (2000) Phenolic acids and derivatives: Studies on the relationship among structure, radical scavenging activity and physicochemical parameters. J. Agric. Food Chem., 48, 2122-2126.
22. Tapiero,H. et al. (2002) Polyphenols: Do they play a role in the prevention of human pathologies? Biomed. Pharmacother., 56, 200-207.
23. Kono, Y. et al. (1997) Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and introgen. Biochim. Biophys. Acta 1335, 335-342.
24. Nardini,M. et al. (2001) Modulation of ceramide-induced NF-kB binding activity and apoptotic response by caffeic acid in U937 cells: comparison with other antioxidants. Free Radic. Mol. Med., 30 722-733.
25. Koshihara,Y. et al. (1984) Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim. Biophys. Acta, 792, 92-97.
26. Nardini,M. et al. (2000) In vitro inhibition on the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin rich pine bark (Pinus marittima) extract. Biochim. Biophys. Acta, 1474, 219-225.
27. Sud'Ina,G.F. et al. (1993) Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett., 329, 21-24.
28. Russo,A. et al. (2002) Antioxidant activity of propolis: Role of caffeic acid phenethyl ester and galangin. Fitoterapia, 73 (suppl. 1), S21-S29.
29. Natarajan,K. et al. (1996) Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc. Natl Acad. Sci. USA, 93, 9090-9095.
30. Song,Y.S. et al. (2002) Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett., 175, 53-61.
31. Chung,T.W. et al. (2004) Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J., 18, 1670-1681.
32. Liao,H.F. et al. (2003) Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J. Agric. Food Chem., 51, 7907-7912.
33. Siquet,C. et al. (2006) Antioxidant profile of dihydroxy-and trihydroxyphenolic acids - a structure-activity relationship study. Free Radic. Res., 40, 433-442
34. Silva,F.A.M. et al. (2001) Effects of phenolic propyl esters on the oxidative stability of refined sunflower oil. J. Agric. Food Chem., 49, 3936-3941.